Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
Study Information
Alliance Study ID: CALGB-9663
NCT Study ID (ClinicalTrials.gov): NCT00002924
Alliance Committee: Genitourinary Cancer
Disease or Cancer Type: Prostate Cancer
Alliance Study Chair: Mary-Ellen Taplin, MD
Status: COMPLETED
Study Description
RATIONALE: Gene mutations may make prostate cancer cells unable to attach to androgens. This may permit the growth of prostate cancer. Gene testing may improve the identification of patients with advanced prostate cancer.
PURPOSE: Clinical trial to study the androgen receptor gene in patients with prostate cancer that is not responsive to hormone therapy.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information